| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Nov 26, 2025 | EXELIXIS, INC. | Director | Buy | 87.5 | +27,532 | 1.78% | ✗ | $1.2M |
| May 28, 2024 | May 30, 2024 | EXELIXIS, INC. | Director | Buy | 100.0 | +425,000 | 37.98% | ✗ | $8.7M |
| Feb 21, 2024 | Feb 22, 2024 | EXELIXIS, INC. | Director | Buy | 100.0 | +190,000 | 20.45% | ✗ | $3.9M |
| Dec 14, 2023 | Dec 14, 2023 | Liquidia Corp | Director | Buy | 100.0 | +1,117,318 | 10.99% | ✗ | $8M |
| Sep 6, 2022 | Sep 7, 2022 | Liquidia Corp | Director | Buy | 87.5 | +250,000 | 2.41% | ✗ | $1.4M |
| Aug 3, 2022 | Aug 5, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 85.0 | +301,182 | 1.35% | ✗ | $526.6K |
| Jul 29, 2022 | Aug 2, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 90.0 | +620,466 | 2.93% | ✗ | $953.6K |
| Jun 13, 2022 | Jun 15, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 72.5 | +100,000 | 0.96% | ✗ | $170K |
| Jun 2, 2022 | Jun 6, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 85.0 | +450,000 | 2.23% | ✗ | $879K |
| May 25, 2022 | May 26, 2022 | Liquidia Corp | Director | Buy | 75.0 | +79,400 | 0.77% | ✗ | $270K |
| May 17, 2022 | May 19, 2022 | Liquidia Corp | Director | Buy | 87.5 | +221,104 | 1.09% | ✗ | $1.3M |
| May 6, 2022 | May 10, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 92.5 | +488,350 | 2.51% | ✗ | $1.4M |
| Apr 28, 2022 | May 2, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 87.5 | +400,000 | 2.20% | ✗ | $1.1M |
| Apr 18, 2022 | Apr 18, 2022 | Liquidia Corp | Director | Buy | 100.0 | +1,764,705 | 21.19% | ✗ | $9M |
| Apr 11, 2022 | Apr 13, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 85.0 | +195,000 | 1.09% | ✗ | $741.2K |
| Apr 6, 2022 | Apr 8, 2022 | STANDARD BIOTOOLS INC. | 10% Owner | Buy | 92.5 | +509,573 | 3.02% | ✗ | $1.9M |